Semaglutide Linked to Lower Dementia Risk

Executive Summary:

• Semaglutide reduces 5-year predicted dementia risk by 26%
• Weight loss may contribute to the reduced risk
• More research is needed to understand the direct effects of semaglutide

The Internet’s Verdict: 80% Hopeful, 20% Cautious

Understanding the Study

A recent study has found that semaglutide is linked to a 26% lower 5-year predicted dementia risk. This news has generated significant interest and discussion.

Forum Voices

Some have expressed excitement about the potential benefits of semaglutide, while others have raised questions about the role of weight loss in the reduced risk.

So has anyone managed to separate the effects of semaglutide from the effects of weight loss? If this is caused by the weight loss, it is a little disappointing that public health didn’t act quicker – lots of people have been overweight for a century now, so literally 10’s of millions of people could have been saved from dementia had action been taken 100 years ago.

Others have noted that the study took into account the effects of BMI on the reduced risk.

Although it’s encouraging, they do mention that the reduction in the BMI also have an effect (they take it into the consideration by lowering the β −0.092 to β −0.066 (P < 0.001)). Just skimming through it, it’s possible there are direct benefits, but it could also be other environmental factor. This study will most likely generate others that give us more insight in the future.

Next Steps

While the study’s findings are promising, more research is needed to fully understand the effects of semaglutide on dementia risk. As one commenter noted, lower calorie consumption in general has been linked to longevity.

Isn’t lower calorie consumption in general correlated to longevity? (Assuming no major malnutrition)

Focus Keyword: Semaglutide Dementia